FEMKX
Price
$60.37
Change
+$0.49 (+0.82%)
Updated
Sep 11 closing price
Net Assets
11.33B
FNWFX
Price
$108.68
Change
-$0.72 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

FEMKX vs FNWFX

FEMKX vs FNWFX Comparison Chart in %
View a ticker or compare two or three
VS
FEMKX vs. FNWFX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMKX is a StrongBuy and FNWFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 90B vs. FEMKX (11.3B). FNWFX pays higher dividends than FEMKX: FNWFX (1.24) vs FEMKX (0.04). FEMKX was incepted earlier than FNWFX: FEMKX (36 years) vs FNWFX (10 years). FEMKX (0.86) is less costly to investors than FNWFX (0.57). FNWFX is a more actively managed with annual turnover of: 46.00 vs. FEMKX (31.00). FEMKX has a lower initial minimum investment than FNWFX: FEMKX (0) vs FNWFX (1000000). FEMKX annual gain was more profitable for investors over the last year : 30.66 vs. FNWFX (17.45). FEMKX return over 5 years is better than : 29.53 vs. FNWFX (18.61).
FEMKXFNWFXFEMKX / FNWFX
Total Expense Ratio0.860.57151%
Annual Report Gross Expense Ratio0.860.57151%
Fund Existence36 years10 years-
Gain YTD20.07216.572121%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRA500N/A-
Net Assets11.3B90B13%
Annual Yield % from dividends0.041.243%
Returns for 1 year30.6617.45176%
Returns for 3 years77.1654.72141%
Returns for 5 years29.5318.61159%
Returns for 10 years160.00N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPGX46.890.52
+1.12%
Fidelity Advisor Low-Priced Stock Z
FSMEX50.90N/A
N/A
Fidelity Select Medical Tech and Devcs
MNHIX26.78N/A
N/A
Manning & Napier Pro-Blend Max Term I
LMCCX32.20N/A
N/A
Lord Abbett Mid Cap Stock C
MSAYX24.22N/A
N/A
Morgan Stanley Inst Asia Opp R6